Table 1. Clinical features of MCL with CD10and BCL-6 co-expression.
| Characteristics | CD10 and BCL-6 co-expression | P value | |
|---|---|---|---|
| Yes (n=8) | No (n=87) | ||
| Age (year) | 61.75±7.13 | 58.41±10.85 | 0.397 |
| Sex (male/female) | 7/1 | 71/15 | 0.684 |
| Ki-67 (%) | 63.13±19.45 | 45.00±21.69 | 0.025 |
| WBC (×109/L) | 29.63±35.08 | 13.58±19.05 | 0.038 |
| Hb (g/L) | 106.63±27.25 | 113.23±28.25 | 0.527 |
| PLT (×109/L) | 133.38±73.77 | 184.40±116.71 | 0.239 |
| LDH (IU/L) | 462.00±208.37 | 299.99±174.96 | 0.015 |
| β2-MG (mg/L) | 6.34±2.51 | 3.98±2.79 | 0.021 |
| Classic/variants | 3/5 | 78/9 | 0.001 |
P<0.05 was for having statistically significant difference. WBC, white blood cell; Hb, hemoglobin; PLT, platelet; LDH, lactate dehydrogenase; β2-MG, beta-2 microglobulin.